Pharmaceuticals

Vaxchora Market 2026 benefiting from travel vaccination requirements

March 27, 2026March 27, 2026 by Marketing Posting

The Business Research Company’s 2026 market reports include new capabilities such as market attractiveness scoring and analysis, total addressable market analysis, company scoring matrix, interactive excel data dashboard, improved supply chain analysis, upcoming startups in the market, and overview of key products, aimed at improving the depth, usability, and strategic value of the insights delivered.

How Will The Market Size Of The Vaxchora Market Evolve From 2026 To 2030?

The growth witnessed during the historic period resulted from several factors, including a surge in international journeys to regions where the disease is prevalent, an increase in measures designed to prepare for cholera outbreaks, the proliferation of travel medicine clinics, the receipt of regulatory clearances for oral vaccines, and more robust vaccine distribution systems.

The projected growth throughout the forecast period is fueled by several factors, including heightened investments in global disease prevention efforts, an escalating demand for single-dose vaccines, the expansion of travel health services, a sharpened focus on strategies for outbreak prevention, and increased utilization in humanitarian and emergency response scenarios.

Significant trends expected during the forecast period involve a rising demand for travel-related vaccines, growing public awareness regarding cholera prevention, the increasing adoption of oral vaccine formats, the broadening of global travel immunization programs, and a stronger emphasis on ensuring rapid immunization compliance.

Download the Free Sample Report to Explore Key Market Insights:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20427&type=smp

What Drivers Are Influencing The Vaxchora Market?

The increasing occurrence of cholera cases is projected to fuel the expansion of the vaxchora market going forward. Cholera is an infection triggered by the vibrio cholerae bacterium, leading to severe diarrhea and dehydration from contaminated water or food. The escalation in cholera cases stems from factors such as inadequate sanitation, limited access to clean water, climate change, and increased population mobility to cholera-endemic regions. Vaxchora acts as a preventative measure against cholera by prompting the immune system to generate antibodies targeting Vibrio cholerae serogroup O1, thereby mitigating the chances of severe diarrhea and dehydration associated with cholera infection. For instance, in August 2025, the UK Health Security Agency, a UK-based government agency, reported that EWNI recorded 8 confirmed cholera cases from January to June 2025, which is an increase from the 1 case reported during the same period in 2024. Consequently, the growing frequency of cholera cases is propelling the expansion of the vaxchora market.

Which Segment Areas Are Covered In The Vaxchora Market Analysis?

The vaxchora market covered in this report is segmented –

1) By Clinical Indication: Prevention Of Cholera, Prevention Of Gastrointestinal Infections Caused By Vibrio Cholerae

2) By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Travel Clinics

3) By End User: Adult, Pediatric, Geriatric

What Key Developments And Trends Are Impacting The Vaxchora Market?

A significant development in the vaxchora market is the expansion of vaccination regional approvals, which aims to enhance accessibility and satisfy the increasing demand for cholera prevention in areas prone to the disease and those deemed high-risk. These extended regional approvals are instrumental in improving public health by widening immunization coverage and tackling the continuously growing global need for potent cholera prevention strategies. For example, in September 2024, Bavarian Nordic, a biotechnology company headquartered in Denmark, announced the commercial introduction of Vaxchora. This vaccine is the only single-dose oral vaccine approved in Canada to offer protection against cholera, which is a sudden and severe intestinal infection characterized by acute watery diarrhea. The vaccine is administered as a single oral dose and provides protection within 10 days.

Which Global Companies Are Actively Competing In The Vaxchora Market?

Major companies operating in the vaxchora market are Bavarian Nordic A/S

Read the full vaxchora market report here:

https://www.thebusinessresearchcompany.com/report/vaxchora-global-market-report

Which Regions Are Expected To Experience Rapid Expansion In The Vaxchora Market?

North America was the largest region in the vaxchora market in 2025. The regions covered in the vaxchora market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Request A Tailored Vaxchora Market Research Report For Competitive Advantage:

https://www.thebusinessresearchcompany.com/customise?id=20427&type=smp

Browse Through More Reports Similar to the Global Vaxchora Market 2026, By The Business Research Company

Vasodilators Market Report 2026

https://www.thebusinessresearchcompany.com/report/vasodilators-global-market-report

Peripheral Vasodilator Drugs Market Report 2026

https://www.thebusinessresearchcompany.com/report/peripheral-vasodilator-drugs-global-market-report

Biopreservation Market Report 2026

https://www.thebusinessresearchcompany.com/report/biopreservation-global-market-report

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795